Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
/in International Publications, Newcastle Disease Virus /von 2020-11-28 / Cancers (Basel) 2020 Nov;12(12)Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2020-11-16 / Int J Mol Sci 2020 Nov;21(22)Emerging Immunotherapies in the Treatment of Brain Metastases
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2020-10-26 / Oncologist 2020 Oct;Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2020-10-01 / Arch Razi Inst 2020 Oct;75(3):367-376NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2020-09-28 / J Cell Biochem 2021 Jan;122(1):3-15Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2020-08-28 / Cancer Cell Int 2020;20:420Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2020-08-07 / Cancer Cell Int. 2020;20:380Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways
/in Cervical Cancer, International Publications, Newcastle Disease Virus /von 2020-08-07 / Microb. Pathog. 2020 Aug;147:104438Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit
/in Dendritic Cells, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-07-23 / Biomedicines 2020 Jul;8(8)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Neu in der Corona Ambulanz Köln: PCR Schnelltest
- Vitamin D supplementation to the older adult population in Germany has the cost-saving potential of preventing almost 30,000 cancer deaths per year
- Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study